Table 1 |.
Manipulation | Criteria | Advantages | Disadvantages |
---|---|---|---|
Assessment of behavioural correlates of itch | |||
Loss of neuropeptide function in mice (via genetic KO or siRNA-mediated knockdown) | Impaired itch behaviour and normal pain behaviour | Direct evidence Sensory neuron-specific KO is feasible |
Compensation: multiple related neuropeptides and receptors Time consuming to generate double-KO or triple-KO mice and CKO mice Spinally restricted CKO may not be feasible |
Chemogenetic or optogenetic inhibition or viral, chemical or intersectional genetic ablation of neurons | Impaired itch behaviour and normal pain behaviour | Spinally restricted inhibition/ablation possible Sensory neuron-specific inhibition/ablation possible Ablation can be fast and efficient |
Low level of fidelity of a Cre line Neurotoxin approach may have off-target effects Most acute pain behaviour cannot be appropriately evaluated after cervical inhibition or ablation Genetic compensation Indirect effects |
Loss of neuropeptide function via pharmacological approaches | Impaired itch behaviour and normal pain behaviour | Acute and convenient Agonists may be available Dose-dependent scratching behaviour can be assessed |
Off-target effects Potential presynaptic effects originating in primary afferents Pharmacological artefacts |
Gain of neuropeptide function via pharmacological approaches | Induced itch behaviour and normal pain behaviour | Acute and convenient Agonists may be available Dose-dependent scratching behaviour can be assessed |
Off-target effects Potential presynaptic effects originating in primary afferents Pharmacological artefacts Ceiling or floor effects |
Chemogenetic or optogenetic activation of neurons | Induced itch behaviour and normal pain behaviour | Spinal cervical cord-restricted activation Validation using BB-sap possible Sensory neuron-specific activation of central or peripheral fibres possible |
Low level of fidelity of a Cre line Chemogenetic or optogenetic artefacts Artificial behaviour can only suggest the capacity of fibres and is not necessarily an indicator of an endogenous function of manipulated neurons |
Assessment of neural correlates of itch | |||
Electrophysiological recording of neuronal responses to chemical itch, pain, cooling or scratching | Inhibited by pain stimuli | Single-cell resolution Cell-type recording |
Low level of fidelity of Cre or eGFP mouse lines Lack of specificity of some chemicals (e.g. capsaicin) May not simulate neuropeptide release in freely behaving animals |
BB-sap, bombesin–saporin; CKO, conditional knockout; eGFP, enhanced GFP; KO, knockout; siRNA, small interfering RNA.